Director, Chief Scientific Officer · Edgewise Therapeutics, Inc. · Edgewise Therapeutics, Inc. — Restricted Stock Units
Side
A
Value
—
Shares
32.5K
Price
—
Executed
Aug 12, 2026
Disclosed
Aug 14, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 12 executedAug 14, 2026 disclosed
EWTX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Edgewise Therapeutics, Inc. — Restricted Stock Units
Ticker
EWTX
Shares
32.5K
Price per share
$0
Execution date (reported)
Aug 12, 2026
Owned after transaction
32.5K shares
Days from execution to publication
2
What this establishes
Russell Alan J filed this Form 4 reporting a grant or award of EWTX on Aug 12, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Scientific Officer
Russell Alan Jcik:0001853529
Issuer
Edgewise Therapeutics, Inc.cik:0001710072
Revision history · 0
No field has changed since this record was first ingested.
